Eton Pharmaceuticals shocks investors with major acquisition: Shares explode to 52-week high

Eton Pharmaceuticals has sent shockwaves through the pharmaceutical industry after its shares soared to a 52-week high, fueled by the acquisition of the critical rare ... Read More